Stephanie Silveria

5PUBLICATIONS
29CO-AUTHORS
Tumour immunologyMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 10, 2026
Intratumoral Treg cell ablation elicits NK cell-mediated control of CD8 T cell-resistant tumors.

Chenyu Zhang, Charles Chien, Eglė Jurgaitytė

|Jan 23, 2026
Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity.

Jesse Garcia Castillo, Stephanie Silveria, Leo Schirokauer

|Sep 15, 2025
Epigenetically regulated p53 activity maintains intestinal regulatory T cell identity to prevent inflammation.

Stephanie Silveria, Janneke Gc Peeters, Jenna Vickery

|Nov 15, 2023
Separating the Good from the Bad: Tumor-Infiltrating Tregs Have Increased Fucosylation.

Stephanie Silveria, Michel DuPage

|Mar 03, 2018
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

Jonathan T Sockolosky, Eleonora Trotta, Giulia Parisi

Pageof 1